• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

20 Promising Canadian Digital Health Companies to Watch

by Komal Garewal 07/08/2015 Leave a Comment

WESTERN CANADA

1. Ayogo Health

ayogo

Ayogo’s proprietary platform, Empower, has been deemed effective enough to be designated a Digital Therapeutic. Customizable according to physician or practice goals, the software incorporates elements of gamification and social networking to create sustainable behavior change and long-term healthy habits. The platform has already been adapted for patients with various chronic conditions including obesity, insomnia and Type II diabetes.

Founded: 2011

Founders: Michael Fergusson & Paul Prescod

Category: Patient Engagement

Funding: $2.5 million

Why you should pay attention – Already accredited by companies like Merck, Sanofi, Novartis, Kaiser Permanente and Boehringer Ingelheim, users of the company’s platform have shown a 200% improvement in target health outcomes over control groups.   

2. Cognilab

Cognilab

The Cognilab platform is advertised as being ‘faster, cheaper and more effective’ for creating, crowdsourcing and sharing psychology experiments. Effectively making the World Wide Web a recruiting tool, this platform minimizes a startup’s financial and technological barriers to market entry and allows companies to recruit and capture the data needed to conduct robust clinical trials.

Founded: 2013

Founders: Ladan Mahabadi, Kelsey Hannan & Jose Barrios

Category: Diagnostics

Funding: $212.4 thousand

Why you should pay attention – This UX friendly platform lets scientists and non-technologically savvy patrons produce and distribute surveys to gather pertinent information in a time-sensitive manner. It has the potential to catalyze clinical trials by expanding patient pools to the global community therefore speeding up the relevant approval processes.

3. Contextual Genomics

Contextual Genomics

Of all the health issues in developing countries, cancer is one condition that affects populations on a wide-scale basis without discrimination.  Having crafted diagnostic tests based on gene mutations, this company aims to identify therapeutic targets for patients, acquired drug resistant mutations and mutations that may have prognostic or diagnostic implications for patient care.

Founded: 2012

Founders: David Huntsman, Samuel Aparicio & Sohrab Shah

Category: Diagnostics

Funding: Undisclosed

Why you should pay attention – From breast to colorectal cancer, the data collected by CG’s studies has the ability to significantly impact future studies and treatment processes. The company’s technology is already being utilized for other genetic and hereditary conditions and may have the ability to identify at-risk patients before symptoms develop, giving healthcare systems the ability to expand upon preventative care and save costs.

4. eTreat Medical Diagnostics

eTreatMD

This mobile health company builds apps that offer curated, diagnostic information to patients with chronic conditions that will assist them in effectively managing their health. eTreat’s current suite of apps focus on managing arthritis, skin conditions, muscular/skeletal disorders, chronic wounds and diabetic ulcers. 

Founded: 2014

Founders: Nick Mackinnon, Shanil Gunasekara, Malith Gunasekara & Fartash Vasefi

Category: Diagnostics & Treatment

Funding: Undisclosed

Why you should pay attention –Enabling a greater level of personalized care, patients using eTreat’s apps can take a guided photograph of their condition, receive detailed analysis on their progress over time and share the report of what treatments have the best results with their doctors. The MyHand app has been approved to be marketed as a Class I medical device in Canada, opening the pipeline for the company’s future products.  

5. LifeBooster

Life Booster

The LifeBooster patent-pending system is comprised of three unique wireless sensors that integrates into existing uniforms or gear, has biometric data analysis capabilities and can be used by professionals to conjure customized rehabilitation programs or musculoskeletal injury prevention plans. Based on the data collected, employers can create personal disability management programs or even health and safety training exercises to prevent employee injury. Employers can minimize occupational hazards, lower healthcare costs and maintain a healthy and efficient workforce, thereby ensuring certain levels of productivity.

Founded: 2012

Founders: Stacey Wallin & Bryan Statham

Category: Diagnostics & Technology

Funding: Undisclosed

Why you should pay attention – Moving beyond employee wellness in the mining, oil and gas industries (or those industries which hard labor is required), the technology has great potential for growth in Canada, a country where specialty and post-operative care are often difficult to access in a timely manner.

Pages: Page 1 Page 2 Page 3 Page 4

Tagged With: algorithms, API, Asthma, behavior, big data, Biometric Data, cancer, Caregivers, Catalyze, Circulation, Clinical Trial, Clinical Trial Recruitment, Clinical Trials, COPD, data analytics, decision support, dementia, diabetes, digital health, dna, DNA Testing, Doximity, Drug Discovery, Evidence-based medicine, Facebook, FDA, Figure 1, genomics, google, Google Glass, health insurance, Health Startups, Health Systems, Health Tech Startups, Healthfundr, Heart, heart disease, HIT, Home Care, In-Home Care, intel, Interface Health, Kaiser Permanente, MD, Medical Device, Medical Devices, medication, Medication Adherence, Mental Health, mhealth, mobile health, Notable, Novartis, Pain Management, Patient Adherence, Patient Care, Patient Education, patient engagement, Patient Monitoring, Patient Satisfaction, Personal Health Record, Personalized Medicine, physicians, Population Health, Public Health, remote patient monitoring, Sanofi, sensors, Software Development Kit, telehealth, venture capital, Wireless Sensors, workplace

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Komal Garewal

by Komal Garewal

Komal Garewal is the former Head of Operations & Client Services at MedStartr, the first healthcare crowdfunding platform where she advised startup founders on project optimization, business and product development, marketing strategies, and scaling up methods. She has worked on over 75 crowdfunding projects, which have appeared on platforms ranging from Indiegogo to RocketHub raising over $400k in funding to date.

Like this article? Share it!

  •  
  •  
  •  
  •  
  •  

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |